Endovascular Engineering, Inc. (E2) announced it has secured $42 million in oversubscribed Series B financing to advance its n ...
Drs. Jeffrey E. Hull and Dheeraj K. Rajan discuss technical concepts and ongoing research in this emerging option for hemodialysis access. Dr. Rajan: Dialysis patients need consistent, effective, ...
An association between venous thrombosis and malignancy is well established, with the first description of this phenomenon occurring in 1823.1 Malignancy is associated with a significantly increased ...
Johnson & Johnson MedTech recently launched their Cereglide 92 catheter system for the treatment of acute ischemic stroke.
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
Cerenovus PulseRider Aneurysm Neck Bridging Device T shape, Y shape 2.7–3.5, 3.4–4.5 8.6, 10.6 ...
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
Gore & Associates Gore DrySeal Flex Introducer Sheath 10, 12, 14, 15, 16, 18, 20, 22, 24, 26 0.035 A new standard of flexibility to treat more challenging anatomies ...
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
CVRx, Inc. announced new real-world evidence demonstrating that use of the company’s Barostim implant was associated wit ...
Guerbet announced that its Lipiojoint transient liquid embolic agent received Breakthrough Device status from the United ...
Chronic limb-threatening ischemia (CLTI) is a challenging disease to treat, requiring a tailored approach and comprehensive endovascular toolbox. The goal of treatment is to achieve wound healing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results